Navigation Links
Breckenridge Announces Dismissal of Various Lawsuits Against Macoven Pharmaceuticals in Return for Macoven's Discontinuance of Certain Products
Date:7/9/2013

BOCA RATON, Fla., July 9, 2013 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that Nestle Health Science-Pamlab and Merck & Cie have dismissed their patent litigation against Macoven Pharmaceuticals, LLC., and Breckenridge has dismissed its Lanham Act litigation against Macoven.   In return, Macoven has agreed to immediately and permanently cease all manufacturing, use, sale, offers for sale, importation, distribution, advertising, promotion, marketing its generic, unlicensed L-methylfolate calcium salt products.   Macoven's discontinued products include:  VitaCirc-B, Alz-NAC, L Methylfolate PNV DHA, L-Methylfolate Calcium 7.5, and L-Methylfolate Calcium 15.

Merck & Cie is the exclusive manufacturer and supplier of the ingredient Metafolin® (L-methylfolate calcium), and is the owner of multiple U.S. patents covering Metafolin®.   Nestle Health Science-Pamlab markets the only branded medical foods in the United States which contain Metafolin®.  Since 2007, Breckenridge has served as the exclusive authorized-generic supplier of Nestlé Health Science-Pamlab brands, from folic acid products to Metafolin®-containing medical foods.  

About Breckenridge Pharmaceutical, Inc.
Breckenridge is a privately-held pharmaceutical marketing, research and development company founded in 1983 that markets a broad range of generic prescription products and Medical Foods in many therapeutic categories. The Breckenridge label is recognized by Wholesalers, Distributors, Chains, and Managed Care Accounts, as well as Retail Pharmacies nationwide. The company markets over 60 products in a variety of dosage forms including: Tablets, Capsules, Soft Gel Capsules, Liquids, and Powders.

 


'/>"/>
SOURCE Breckenridge Pharmaceutical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Breckenridge Pharmaceutical signs Letter of Intent with Welding GmbH & Co & SK Chemicals
2. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
3. Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets
4. BiOptix announces low cost Surface Plasmon Resonance Services for Colorado-based researchers
5. Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors
6. Blue Sky BioServices Expands its Executive Team - Announces Appointment of Ted Marple as President and CEO
7. Concord Medical Announces Launch of Mobile Health Application
8. Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy
9. Valeant Pharmaceuticals Announces Closing of Public Offering of Common Shares
10. Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod
11. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Boda
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
(Date:2/23/2017)... 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical ... products for the urology market, will release financial results ... 31, 2016 before the market open on Thursday, March ... a conference call and webcast to discuss its financial ... at 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
Breaking Medicine Technology:
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... 24, 2017 , ... Dr. Ronald E. Hawkins, vice president ... of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean ... Dr. Bell comes to Liberty from the Ohio University Heritage College of Osteopathic ...
(Date:2/24/2017)... Melbourne, Australia (PRWEB) , ... February 24, 2017 , ... ... Press AU) offers Erik Schanssema ’s true account of his paramedic experiences. Schanssema ... post-traumatic stress disorder and his attempts to overcome them. , Schanssema, initially unsure ...
(Date:2/24/2017)... ... 24, 2017 , ... Indiana Fiber Network (IFN) President and CEO Kelly C. ... Dyer started as the Chairman of the Management Committee when IFN was originally formed ... the recruitment of investor/owners and development of the business plan. He became the ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the ... The Jensie Gran Fondo of Marin. For the second year in a row, ... mineral-based sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen to ...
Breaking Medicine News(10 mins):